Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2018 May 1;22(5):557–566. doi: 10.5588/ijtld.17.0609

Figure 3.

Figure 3

ROC curve illustrates the discriminatory power of systemic angiogenic factors in individuals with TBL. ROC curve analysis was performed to assess the sensitivity, specificity and area under the curve using systemic angiogenic factors (VEGF-A, C, VEGF-R2, R3, Ang-2 and TIE2) and to calculate the ability of these factors to differentiate TBL from individuals with LTBI. VEGF = vascular endothelial growth factor; VEGF-R= VEGF receptor; TIE2 = tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains 2; ROC = receiver operating characteristic; TBL = tuberculous lymphadenitis; LTBI = latent tuberculous infection.